Cytokine regulation and the signaling mechanism of osteoclast inhibitory peptide-1 (OIP-1/hSca) to inhibit osteoclast formation

Journal of Bone and Mineral Research

Volumn 18, Issue 3, 2003, Pages 458-465

  Koide, Masanori ^a   Maeda, Hidefumi ^a   Roccisana, Jennifer L ^a   Kawanabe, Noriaki ^a   Reddy, Sakamuri V ^a,b  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Granulocyte macrophage colony forming unit; Interferon ; Osteoclast inhibitory peptide; P c Jun kinase; TNF receptor associated factor 2

Indexed keywords

C PEPTIDE; CYTOKINE; GAMMA INTERFERON; GLYCOSYLPHOSPHATIDYLINOSITOL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1; MEMBRANE PROTEIN; MESSENGER RNA; NEUTRALIZING ANTIBODY; OSTEOCLAST INHIBITORY PEPTIDE 1; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG; MITOGEN ACTIVATED PROTEIN KINASE; PRIMER DNA; PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; THYROID HORMONE RECEPTOR INTERACTING PROTEIN; THYROID-HORMONE-RECEPTOR INTERACTING PROTEIN; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; COLONY FORMING UNIT GM; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MACROPHAGE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; CELL LINE; CYTOLOGY; ENZYMOLOGY; GEL MOBILITY SHIFT ASSAY; GENETICS; METABOLISM; NUCLEOTIDE SEQUENCE; PHYSIOLOGY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE; CYTOKINES; DNA PRIMERS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; OSTEOCLASTS; PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 2; TRANSCRIPTION FACTORS;

EID: 0037369111     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2003.18.3.458     Document Type: Article

References (39)

1. Roodman GD 1996 Advances in bone biology: The osteoclast. Endocr Rev 17:308-332.
2. Takahashi N, Mundy GR, Roodman GD 1986 Recombinant human interferon-gamma inhibits formation of human osteoclast-like cells. J Immunol 137:3544-3549.
3. Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ 1999 Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocrine Rev 20:345-357.
4. Kobayashi K, Takahashi N, Jimi E, Udgawa N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Morinaga T, Higashio K, Martin TJ, Suda T 2000 Tumor necrosis factor a stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med 191:275-286.
5. Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E, Tan H, Elliot G, Kelley MJ, Sarosi I, Wng L, Xia X-Z, Elliot R, Chiu L, Black T, Scully S, Capparelli C, Morony S, Shimamoto G, Bass MB, Boyle WJ 1999 Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA 96: 3540-3545.
6. Takayanagi H, Ogasawara K, Hida S, Chiba T, Murata S, Sato K, Takaoka A, Yokochi T, Oda H, Tanaka K, Nakamura K, Taniguchi T 2000 T-cell-mediated regulation of osteoclastogenesis by signaling cross-talk between RANKL and IFN-γ. Nature 408:600-605.
7. Fox SW, Chambers TJ 2000 Interferon-γ directly inhibits TRANCE induced osteoclastogenesis. Biochem Biophys Res Commun 276:868-872.
8. van't Hof RJ, Ralston SH 2001 Nitric oxide and bone. Immunol 103:255-261.
9. Choi S, Devlin RD, Menaa C, Chung H, Roodman GD, Reddy SV 1998 Cloning and identification of human Sca as a novel inhibitor of osteoclast formation and bone resorption. J Clin Invest 102: 1360-1368.
10. Palfree RG 1996 Ly-6 domain proteins-new insights and new members: A C-terminal Ly-6 domain in sperm acrosomal protein SP-10. Tissue Antigens 48:71-79.
11. Classon BJ, Coverdale L 1996 Genomic organization and expression of mouse thymic shared antigen-1 (TSA-1): Evidence for a processed pseudogene. Immunogenetics 44:222-226.
12. Koide M, Kurihara N, Maeda H, Reddy SV 2002 Identification of the functional domain of osteoclast inhibitory peptide-1/hSca. J Bone Miner Res 17:111-118.
13. Tujioka H, Misumi Y, Takami N, Ikehara Y 1998 Posttranslational modification of glycosylphosphatidylinositol (GPI) specific phospholipase D and its activity in cleavage of GPI anchors. Biochem Biophys Res Commun 251:737-743.
14. Antica M, Wu L, Scollay R 1997 Stem cell antigen 2 expression in adult and developing mice. Immunol Lett 55:47-51.
15. MacNeil I, Kennedy J, Godfrey DI, Jenkins NA, Masciantonio M, Mineo C, Gilbert DJ, Copeland NG, Boyd RL, Zlotnik A 1993 Isolation of a cDNA encoding thymic shared antigen-1. J Immunol 151:6913-6923.
16. Capone MC, Gorman DM, Ching EP, Zlotnik A 1996 Identification through bioinformatics of cDNAs encoding human thymic shared Ag-1/Stem cell Ag-2. J Immunol 157:969-973.
17. Kosugi A, Saitoh S, Narumiya S, Miyake K, Hamaoka T 1994 Activation induced expression of thymic shared antigen-1 on T lymphocytes and its inhibitory role for TCR mediated IL-2 production. Int Immunol 6:1967-1976.
18. Noda S, Kosugi A, Saitoh S, Narumiya S, Hamaoka T 1996 Protection from anti-TCR/CD3 induced apoptosis in immature thymocytes by a signal through thymic shared antigen-1/stem cell antigen-2. J Exp Med 183:2355-2360.
19. Kosugi A, Saitoh S, Noda S, Miyake K, Yamashita Y, Kimoto M, Ogta M, Hamaoka T 1998 Physical and functional association between thymic shared antigen-1/stem cell antigen-2 and the T cell receptor complex. J Biol Chem 273:12301-12306.
20. Menaa C, Kurihara N, Roodman GD 2000 CFU-GM-derived cells form osteoclasts at a very high efficiency. Biochem Biophys Res Commun 267:943-946.
21. Chomczynski P, Sacchi N 1987 Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
22. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burges T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ 1988 Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176.
23. Takahashi N, Yamana H, Yoshiki S, Roodman GD, Mundy GR, Jones SJ, Boyde A, Suda T 1988 Osteoclast like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures. Endocrinology 122:1373-1382.
24. Derijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M, Davis RJ 1994 JNK1: A protein kinase stimulated by UV light and Ha-ras that binds and phosphorylates the c-Jun activation domain. Cell 76:1025-1037.
25. Andrews NC, Faller DV 1991 A rapid micropreparation technique for extraction of DNA binding proteins from limiting numbers of mammalian cells. Nucleic Acid Res 19:2499.
26. Battaglino R, Kim D, Fu J, Vaage B, Fu XY, Stashenko P 2002 c-Myc is required for osteoclast differentiation. J Bone Miner Res 17:763-773.
27. Shevde NK, Bendixen AC, Dienger KM, Pike JW 2000 Estrogen suppress RANK ligand induced osteoclast differentiation via a stromal cell independent mechanism involving c-Jun repression. Proc Natl Acad Sci USA 97:7829-7834.
28. Zhang YH, Heulsmann A, Tondravi MM, Mukherjee A, Abu-Amer Y 2001 Tumor necrosis factor alpha (TNF) stimulates RANKL induced osteoclastogenesis via coupling of TNF type I receptor and RANK signaling pathways. J Biol Chem 276:563-568.
29. Horowitz MC, Fields A, Demeo D, Qian HY, Bothwell ALM, Trepman E 1994 Expression and regulation of Ly6 differentiation antigens by murine osteoblasts. Endocrinology 135:1032-1043.
30. Saitoh S, Kosugi A, Noda S, Yamamoto N, Ogata M, Minami Y, Miyake K, Hamaoka T 1995 Modulation of TCR-mediated signaling pathway by thymic shared antigen-1 (TSA-1)/stem cell antigen-2 (Sca-2). J Immunol 155:5574-5581.
31. Kong YY, Feige V, Sarosi I, Bolon B, Tafuri A, Morony S, Capparelli C, Li J, Elliott R, McCabe S, Wong T, Campagnuolo G, Moran E, Bogoch ER, Van G, Nguyen LT, Ohashi PS, Lacey DL, Fish E, Boyle WJ, Penninger JM 1999 Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature 402:304-309.
32. Khodadoust MM, Khan KD, Park E, Bothwell AL 1998 Distinct regulatory mechanisms for interferon-α/β (IFN-α/β)-and IFN-γ mediated induction of Ly-6E gene in B cells. Blood 92:2399-2409.
33. Horwood NJ, Elliott J, Martin TJ, Gillespie MT 2001 IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro. J Immunol 166:4915-4921.
34. Weitzmann MN, Cenci S, Rifas L, Brown C, Pacifici R 2000 Interleukin-7 stimulates osteoclast formation by up-regulating T-cell production of soluble osteoclastogenic cytokines. Blood 96:1873-1878.
35. Tominaga K, Yoshimoto T, Torigoe K, Kurimoto M, Matsui K, Hada T, Okamuri H, Nakanishi K 2000 IL-12 synergizes with IL-18 or IL-1β for IFN-γ production from human T cells. Int Immunol 12:151-160.
36. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Cegg L, Hughes TM, Hill D, Pattison W, Campbell P, Boyle WJ 1997 Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89:309-319.
37. Yeh WC, Shahinian A, Speiser D, Kraunus J, Billia F, Wakeham A, de la Pompa JL, Ferrick D, Hum B, Iscove N, Ohashi P, Rothe M, Goeddel DV, Mark TW 1997 Early lethality, functional NF-κB activation and increased sensitivity to TNF induced cell death in TRAF-2 deficient mice. Immunity 7:715-725.
38. Lomaga MA, Yeh WC, Sarosi I, Duncan GS, Furlonger C, Ho A, Morony S, Capparelli C, Van G, Kauman S van der Heiden A, Itie A, Waleham A, Khoo W, Sasaki T, Cao Z, Penninger JM, Paige CJ, Lacey DL, Dunstan CR, Boyle WJ, Golddel DV, Mak TW 1999 TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40 and LPS signaling. Genes Develop 13:1015-1024.
39. Takayanagi H, Kim S, Matsuo K, Suzuki H, Suzuki T, Sato K, Yokochi T, Oda H, Nakamura K, Ida N, Wagner EF, Taniguchi T 2002 RANKL maintains bone homeostasis through c-Fos dependent induction of interferon-β. Nature 416:744-749.